Biotech Accounting Services

Financial Solutions for Life Science Innovators

Biotech Accounting Services Designed to Accelerate Discovery and Build Investor Confidence

Your research is pushing boundaries. Your financial systems should support that momentum—not slow it down.

We help biotech companies build the financial infrastructure needed to manage R&D spending, meet compliance standards, and scale from lab to market.

Biotech research team and financial expert collaborating in laboratory, supporting life science financial management.

Trusted by biotech industry leaders:

Financial Clarity for the Path from Bench to Breakthrough.

Biotech startups face unique challenges—long development timelines, complex funding structures, and strict regulatory demands. Generic accounting simply won’t cut it.

That’s why we specialize in life science financial management, helping you translate scientific progress into clear, investor-ready financial narratives—without disrupting your research flow.

Biotech scientist examining data display, supporting financial clarity for life science innovators.

Built for Biotech. Trusted by Innovators

Business Owners Trust Us
0 +
Accounting Experts
0 +
Industries Served
0 +
Years of Experience
0 +

Strategic Financial Partnership for Biotech Innovation

Why Life Science Founders Partner With Us.

Life Science Financial Expertise

We understand the financial needs of therapeutic, diagnostic, and platform biotech models. You focus on discovery—we’ll handle the dollars.

01

Benchmarking & Development Analysis

Compare burn rates, timelines, and capital efficiency across therapeutic areas. We give you real-world financial context for investor meetings.

02

Investor Relationship Support

Over $400M in biotech financing has flowed through our reporting. We deliver board-ready reports, diligence-ready data rooms, and financial systems investors trust.

03

Program Analytics Dashboard

We bridge the gap between your lab and your ledger. Our dashboards link KPIs like regulatory milestones and capital deployment to actionable strategy.

04

Compliance-First Foundation

From grant audits to IPO prep, we bake compliance into your financial systems. Stay focused on your pipeline—not legal headaches.

05

Scalable Financial Architecture

From preclinical to commercial, our systems grow with you. No disruptive migrations—just seamless scaling across research stages and global expansion.

06

Frequently Asked Questions

Common Questions, Straightforward Answers.

Here are some of the frequently asked questions and their best answers for your clarification.

What accounting services do biotech companies need?
Biotech companies need accounting that is built around long development timelines, complex funding structures, and strict regulatory requirements. The core needs include R&D expense tracking under IRS Section 174, grant compliance and segregated fund management, clinical trial accruals, GAAP-compliant financial reporting, burn rate and runway monitoring, and fractional CFO support for investor relations and fundraising. General accounting firms are not set up to handle the financial complexity that comes with life science operations.

Every dollar spent on research and development needs to be categorized, documented, and tracked against the correct cost center from day one. This includes personnel costs, lab consumables, equipment, third-party research services, regulatory fees, and software used in R&D. Under IRS Section 174, R&D costs must now be amortized over several years rather than fully deducted in the year incurred, which makes accurate classification and documentation more important than ever. Poor R&D tracking is one of the most common reasons biotech companies lose tax credits or run into problems during audits.

Most early-stage biotech companies rely on non-dilutive funding from sources like SBIR, STTR, NIH, NSF, and private foundations. Each grant comes with specific reporting requirements, spending restrictions, and audit obligations. Grant funds need to be tracked separately from general operating funds, categorized by the expense types the grant allows, and reported back to the granting agency on a regular schedule. Mixing restricted grant funds with operating finances is one of the fastest ways to trigger compliance problems or lose eligibility for future funding.
A clinical trial accrual is an accounting entry that records the cost of clinical work that has been performed but not yet invoiced. For biotech companies running trials with multiple sites and investigators, expenses are often incurred weeks or months before a bill arrives. Without monthly accrual processes that capture patient enrollment data, site activation costs, and investigator payments in real time, your financial statements will not reflect what is actually happening in your trials. This creates credibility problems with investors and can cause surprises during due diligence.
Most biotech startups need fractional CFO support earlier than founders expect. The complexity of managing multiple funding sources, reporting to investors, preparing for grant audits, and planning around clinical milestones requires senior financial judgment, not just bookkeeping. A fractional CFO with life science experience helps you build the financial models investors expect, manage burn rate against your development timeline, and structure capital efficiently across equity, grants, and partnerships. For most biotech companies, this becomes critical at the seed or pre-Series A stage.
Biotech investors focus on a specific set of metrics that go beyond standard profit and loss statements. They want to see program-level R&D spend broken down by development stage, burn rate and runway projections tied to clinical milestones, cash flow forecasting across multiple funding sources, and GAAP-compliant financial statements with clear footnote disclosures on R&D classification and grant accounting. Companies that can present this level of financial detail move through due diligence significantly faster than those that cannot.
Yes. Fortress Accounting is fully remote and works with biotech and life science companies across the United States. We handle R&D expense tracking, grant compliance, clinical trial accounting, tax planning, investor-ready financial reporting, and fractional CFO services for biotech companies from preclinical through commercial stage.

Still have questions? Contact us.